Cleared Special

K103417 - HALIFAX BIOMEDICAL TANATLUM BEAD SET

K103417 is the FDA 510(k) clearance for HALIFAX BIOMEDICAL TANATLUM BEAD SET by Halifax Biomedical, Inc.. It is a Class 2 General & Plastic Surgery device (product code NEU) cleared through the Special 510(k) pathway after a 218-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
218d
Days
Class 2
Risk

K103417 is an FDA 510(k) clearance for the HALIFAX BIOMEDICAL TANATLUM BEAD SET. Classified as Marker, Radiographic, Implantable (product code NEU), Class II - Special Controls.

Submitted by Halifax Biomedical, Inc. (Lake Hopatcong, US). The FDA issued a Cleared decision on June 28, 2011 after a review of 218 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4300 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Halifax Biomedical, Inc. devices

Submission Details

510(k) Number K103417 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 2010
Decision Date June 28, 2011
Days to Decision 218 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
103d slower than avg
Panel avg: 115d · This submission: 218d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NEU Marker, Radiographic, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - NEU Marker, Radiographic, Implantable

All 56
Devices cleared under the same product code (NEU) and FDA review panel - the closest regulatory comparables to K103417.
BNX Fine Needle Aspiration System
K142198 · Covidien, LLC · Oct 2014
ECHO TIP ULTRA FIDUCIAL NEEDLE
K141356 · Wilson-Cook Medical, Inc. · Jun 2014
SENOMARK ULTRA BREAST TISSUE MARKER
K123911 · C.R. Bard, Inc. · Jan 2013
SECRMARK BIOPSY SITE MARKING SYSTEM
K102768 · Hologic, Inc. · Dec 2010
ULTRACLIP II US WING AND COIL, MODELS: 862017U, 864017U
K090547 · C.R. Bard, Inc. · Mar 2009
INTERV BRAND V-MARK BREAST BIOPSY SITE MARKER WITH TITANIUM ANCHOR
K053518 · Medical Device Technologies, Inc. · Jan 2006